Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

Adenoviral Conjunctivitis Clinical Trial

Official title:
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis

Status Completed

Clinical Trial Summary

A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Placebo in the Treatment of Adenoviral Conjunctivitis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03749317
Study type	Interventional
Source	IVIEW Therapeutics Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	December 19, 2019
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01532336` - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis	Phase 2
Terminated	`NCT02998554` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo	Phase 3
Terminated	`NCT02998541` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo	Phase 3
Completed	`NCT02472223` - Reducing Adenoviral Patient Infected Days	N/A
Terminated	`NCT00901693` - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis	Phase 2
Withdrawn	`NCT03009799` - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)	Phase 2
Active, not recruiting	`NCT03856645` - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Phase 2
Completed	`NCT00266734` - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears	N/A